189 related articles for article (PubMed ID: 35670085)
1. The predictive value of the sFlt-1/PlGF ratio in suspected preeclampsia in a New Zealand population: A prospective cohort study.
Hughes RCE; Phillips I; Florkowski CM; Gullam J
Aust N Z J Obstet Gynaecol; 2023 Feb; 63(1):34-41. PubMed ID: 35670085
[TBL] [Abstract][Full Text] [Related]
2. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
[TBL] [Abstract][Full Text] [Related]
3. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
4. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dilba P; Schoedl M; Hund M; Verlohren S
N Engl J Med; 2016 Jan; 374(1):13-22. PubMed ID: 26735990
[TBL] [Abstract][Full Text] [Related]
6. Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?
Sabrià E; Lequerica-Fernández P; Ganuza PL; Ángeles EE; Escudero AI; Martínez-Morillo E; Alvárez FV
Clin Chem Lab Med; 2018 Jan; 56(2):303-311. PubMed ID: 28841572
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia.
Bian X; Biswas A; Huang X; Lee KJ; Li TK; Masuyama H; Ohkuchi A; Park JS; Saito S; Tan KH; Yamamoto T; Dietl A; Grill S; Verhagen-Kamerbeek WDJ; Shim JY; Hund M
Hypertension; 2019 Jul; 74(1):164-172. PubMed ID: 31188674
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women.
Sovio U; Gaccioli F; Cook E; Hund M; Charnock-Jones DS; Smith GC
Hypertension; 2017 Apr; 69(4):731-738. PubMed ID: 28167687
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
[TBL] [Abstract][Full Text] [Related]
10. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.
Palmrich P; Kalafat E; Pateisky P; Schirwani-Hartl N; Haberl C; Herrmann C; Khalil A; Binder J
Ultrasound Obstet Gynecol; 2024 May; 63(5):619-626. PubMed ID: 37774098
[TBL] [Abstract][Full Text] [Related]
12. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.
Stolz M; Zeisler H; Heinzl F; Binder J; Farr A
Pregnancy Hypertens; 2018 Jan; 11():54-60. PubMed ID: 29523274
[TBL] [Abstract][Full Text] [Related]
13. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.
Hund M; Allegranza D; Schoedl M; Dilba P; Verhagen-Kamerbeek W; Stepan H
BMC Pregnancy Childbirth; 2014 Sep; 14():324. PubMed ID: 25230734
[TBL] [Abstract][Full Text] [Related]
14. Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study.
Ohkuchi A; Saito S; Yamamoto T; Minakami H; Masuyama H; Kumasawa K; Yoshimatsu J; Nagamatsu T; Dietl A; Grill S; Hund M
Hypertens Res; 2021 Jul; 44(7):813-821. PubMed ID: 33727707
[TBL] [Abstract][Full Text] [Related]
15. Maternal and Perinatal Outcomes Associated With Extremely High Values for the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio.
Villalaín C; Herraiz I; Valle L; Mendoza M; Delgado JL; Vázquez-Fernández M; Martínez-Uriarte J; Melchor Í; Caamiña S; Fernández-Oliva A; Villar OP; Galindo A
J Am Heart Assoc; 2020 Apr; 9(7):e015548. PubMed ID: 32248765
[TBL] [Abstract][Full Text] [Related]
16. Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1-2-3 and sFlt-1: PlGF ratio.
Bremner L; Gill C; Seed PT; Conti-Ramsden F; Webster L; Fleminger J; Chappell LC; Shennan A; Bramham K
Pregnancy Hypertens; 2022 Mar; 27():96-102. PubMed ID: 34979346
[TBL] [Abstract][Full Text] [Related]
17. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
18. Decision Threshold for Kryptor sFlt-1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting.
Andersen LLT; Helt A; Sperling L; Overgaard M
J Am Heart Assoc; 2021 Sep; 10(17):e021376. PubMed ID: 34459248
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic factors for planning fetal surveillance in fetal growth restriction and small-for-gestational-age fetuses: A prospective observational study.
Bonacina E; Mendoza M; Farràs A; Garcia-Manau P; Serrano B; Hurtado I; Ferrer-Oliveras R; Illan L; Armengol-Alsina M; Carreras E
BJOG; 2022 Oct; 129(11):1870-1877. PubMed ID: 35303394
[TBL] [Abstract][Full Text] [Related]
20. A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1/PlGF ratio and NT-proBNP as biomarkers.
Lafuente-Ganuza P; Lequerica-Fernandez P; Carretero F; Escudero AI; Martinez-Morillo E; Sabria E; Herraiz I; Galindo A; Lopez A; Martinez-Triguero ML; Alvarez FV
Clin Chem Lab Med; 2020 Feb; 58(3):399-407. PubMed ID: 31734648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]